相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Evidence for the Complexity of the Population Structure ofMycobacterium tuberculosisIncreases the Diagnostic and Biologic Challenges
Véronique Dartois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
Moloko C. Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action
Leonard Amaral et al.
ANTIBIOTICS-BASEL (2017)
Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis
Melissa D. Chengalroyen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
Yanmin Hu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Development of an In Vitro Assay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria
Jessica Loraine et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
Obolbek Turapov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
Roger K. Verbeeck et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Mechanisms of bacterial persistence during stress and antibiotic exposure
Alexander Harms et al.
SCIENCE (2016)
The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity
Hong-Wei Su et al.
NATURE MICROBIOLOGY (2016)
Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
Carolline Araujo-Mariz et al.
PLOS ONE (2016)
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis
Ben Gold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA
Dmitriy V. Ignatov et al.
BMC GENOMICS (2015)
Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms
Giulia Manina et al.
CELL HOST & MICROBE (2015)
Differential Influence of Nutrient-Starved Mycobacterium tuberculosis on Adaptive Immunity Results in Progressive Tuberculosis Disease and Pathology
Jes Dietrich et al.
INFECTION AND IMMUNITY (2015)
Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum
M. Ayrapetyan et al.
INFECTION AND IMMUNITY (2015)
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson et al.
LANCET (2015)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo
Yanmin Hu et al.
FRONTIERS IN MICROBIOLOGY (2015)
Sterilizing Activity of Thioridazine in Combination with the First-Line Regimen against Acute Murine Tuberculosis
Noton K. Dutta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Abdullah Alsultan et al.
DRUGS (2014)
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Philana Ling Lin et al.
NATURE MEDICINE (2014)
Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states
Elena G. Salina et al.
OPEN BIOLOGY (2014)
The importance of the viable but non-culturable state in human bacterial pathogens
Laam Li et al.
FRONTIERS IN MICROBIOLOGY (2014)
Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis
Kristina Shigyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Reduced Drug Uptake in Phenotypically Resistant Nutrient-Starved Nonreplicating Mycobacterium tuberculosis
Jansy Sarathy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Resistance to environmental stresses by Vibrio vulnificus in the viable but nonculturable state
Joanna Nowakowska et al.
FEMS MICROBIOLOGY ECOLOGY (2013)
Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel
Krishna Kannan et al.
CELL (2012)
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Fresh Approaches to Anti-Infective Therapies
Carl Nathan
SCIENCE TRANSLATIONAL MEDICINE (2012)
Mycobacterium tuberculosis Can Utilize Heme as an Iron Source
Christopher M. Jones et al.
JOURNAL OF BACTERIOLOGY (2011)
Rifampin Stability in 7H9 Broth and Lowenstein-Jensen Medium
Xia Yu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification
Margarita O. Shleeva et al.
TUBERCULOSIS (2011)
Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis
Shinya Watanabe et al.
PLOS PATHOGENS (2011)
Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum
Galina V. Mukamolova et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability
Martin Gengenbacher et al.
MICROBIOLOGY-SGM (2010)
The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
Dick van Soolingen et al.
PLOS ONE (2010)
Taming Tuberculosis: A Challenge for Science and Society
Carl Nathan
CELL HOST & MICROBE (2009)
Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV-Infected Cohort of Adults with Tuberculosis from Botswana
Sekai Chideya et al.
CLINICAL INFECTIOUS DISEASES (2009)
Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance
Luiz Pedro S. de Carvalho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration
Charles D. Sohaskey
JOURNAL OF BACTERIOLOGY (2008)
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum
Natalie J. Garton et al.
PLOS MEDICINE (2008)
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
Sang Hyun Cho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
New insights into the function of granulomas in human tuberculosis
T Ulrichs et al.
JOURNAL OF PATHOLOGY (2006)
Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates
ZF Xie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis
D Yee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide
YM Hu et al.
JOURNAL OF BACTERIOLOGY (2000)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
分享论文
